Literature DB >> 1239513

Production of mastitis in mice with human and bovine ureaplasmas (T-mycoplasmas).

C J Howard, J C Anderson, R N Gourlay, D Taylor-Robinson.   

Abstract

Five ureaplasmas (T-mycoplasmas) of human origin and four of bovine origin were inoculated into the mammary glands of mice. The strains multiplied and neutrophils were observed in sections of infected glands. Some of the glands were macroscopically inflamed, albeit slightly, at necropsy but none of the mice showed any sign of disease during the course of the experiments. All nine ureaplasma strains produced mastitis in BSVS mice and the mammary glands of mice appear more susceptible to ureaplasmas than the udders of cows or goats. Mouse mastitis is suggested as being a suitable small animal model for studying ureaplasma infections.

Entities:  

Mesh:

Year:  1975        PMID: 1239513     DOI: 10.1099/00222615-8-4-523

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Experimental animal infections with Mycoplasma hominis and Ureaplasma urealyticum.

Authors:  S J Kraus; N F Jacobs; F W Chandler; E S Arum
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  The ovine mammary gland as an experimental model to determine the virulence of animal ureaplasmas.

Authors:  H J Ball; D P Mackie
Journal:  J Hyg (Lond)       Date:  1985-10

3.  Experimental mycoplasma mastitis in mice.

Authors:  J C Anderson; C J Howard; R N Gourlay
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

4.  Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.

Authors:  G Piec; J Mirkovitch; S Palacio; P F Mühlradt; R Felix
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.

Authors:  A Kaufmann; P F Mühlradt; D Gemsa; H Sprenger
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice.

Authors:  U Deiters; P F Mühlradt
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.

Authors:  Anke Lührmann; Ursula Deiters; Julia Skokowa; Michaela Hanke; Johannes E Gessner; Peter F Mühlradt; Reinhard Pabst; Thomas Tschernig
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.